KGK Synergize, Inc.
Records under this name other than patents KGK Synergize, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 9 of 9 · Back to KGK Synergize, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,956,257 | Canola extracts containing high levels of phenolic acids Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,172,772 | Methods of skin whitening by use of canola extracts Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,132,117 | Compositions and methods for glycemic control of subjects with impaired fasting glucose Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,610,276 | Compositions and methods for glycemic control of subjects with impaired fasting glucose Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,125,887 | Canola extracts containing high levels of phenolic acids Formerly held Term ended Term ended Oct 27, 2025 · USPTO record | Term ended | Term ended Oct 27, 2025 | USPTO record |
| US 6,239,114 | Compositions and methods for treatment of neoplastic diseases with combinations of limonoids, flavonoids and tocotrienols Formerly held Term ended Term ended Jan 12, 2020 · USPTO record | Term ended | Term ended Jan 12, 2020 | USPTO record |
| US 6,987,125 | Compositions and methods of treating, reducing and preventing cardiovascular diseases and disorders with polymethoxyflavones Formerly held Term ended Term ended Oct 6, 2018 · USPTO record | Term ended | Term ended Oct 6, 2018 | USPTO record |
| US 7,683,095 | Compositions and Methods of Treating, Reducing and Preventing Cardiovascular Diseases and Disorders with Polymethoxyflavones Formerly held Term ended Ended no later than Oct 6, 2018 · Low confidence | Term ended | Ended no later than Oct 6, 2018 | Low confidence |
| US 6,251,400 | Compositions and methods of treatment of neoplastic diseases and hypercholesterolemia with citrus limonoids and flavonoids and tocotrienols Formerly held Term ended Term ended Sep 26, 2017 · USPTO record | Term ended | Term ended Sep 26, 2017 | USPTO record |